Variable

Cumulative Survival (%)

Clinical Stage

I

676/687

(98.4)

IIA

815/845

(96.5)

IIB

526/568

(92.6)

IIIA

389/143

(96.5)

IIIB

165/224

(73.7)

IIIC

41/52

(78.9)

IV

33/54

(61.1)

Unknown

126/297

(42.4)

Grouped Stages

Early

2.017/2.100

(96.1)

Advanced

595/709

(83.9)

Metastatic

33/54

(61.1)